Viral Vector Hantavirus Nucleoprotein Antigen Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a significant need for effective prophylactic and therapeutic measures against Hantavirus infections, as current treatments are limited and no licensed vaccine exists, with existing treatments mainly focusing on symptom management rather than prevention or cure.
Innovation Solution
Development of viral and bacterial vectors encoding Hantavirus nucleoprotein or antigenic fragments to stimulate an immune response, utilizing non-replicating poxvirus vectors or adenovirus vectors to deliver nucleic acid sequences encoding Hantavirus NP, inducing a protective immune response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If viral or bacterial vectors encoding Hantavirus nucleoprotein are used to stimulate immune response, then immunogenicity and protective efficacy are improved, but device complexity and manufacturing difficulty increase
Solution Approach 1:
Viral vectors (such as adenovirus or poxvirus) or bacterial vectors serve as intermediaries to deliver Hantavirus nucleoprotein antigens into host cells. These vectors act as mediators that facilitate antigen presentation to the immune system, thereby enhancing immunogenicity and protective efficacy without requiring direct administration of purified viral antigens
Solution Approach 2:
The invention uses vectors that carry nucleic acid sequences encoding Hantavirus nucleoprotein to produce copies of the antigen within host cells. This copying mechanism ensures sustained antigen expression and presentation, improving the reliability and duration of immune response compared to single-dose antigen administration
2Reliability
If viral vectors are used to deliver Hantavirus NP nucleic acid sequences, then immune response strength is improved, but manufacturing precision and quality control difficulty increase
Solution Approach 1:
The viral or bacterial vectors used in this invention are multi-functional platforms that can deliver Hantavirus nucleoprotein antigens and also serve as immunogenic carriers. These vectors have been previously characterized and validated for safety and immunogenicity, allowing for standardized manufacturing processes and quality control protocols across different viral vector platforms
Solution Approach 2:
The invention employs well-established viral vector systems with known physical and biological parameters (such as replication competence, tissue tropism, and immunogenicity profiles). By selecting vectors with optimized parameters for antigen delivery and immune stimulation, the invention achieves strong immune responses while maintaining manageable manufacturing precision requirements through parameter standardization
3Duration of action of stationary object
If nucleic acid sequences encoding Hantavirus NP are delivered via vectors, then duration of protective action is improved, but loss of time in vector development and production increases
Solution Approach 1:
The viral or bacterial vectors are pre-engineered and validated before being used to deliver Hantavirus nucleoprotein antigens. This preliminary preparation of the vector platform allows for rapid deployment once the antigen sequence is identified, reducing the overall development time while ensuring sustained protective action through the vector's ability to produce antigen over time
Solution Approach 2:
The viral or bacterial vectors enable continuous production and presentation of Hantavirus nucleoprotein antigen within host cells over an extended period. This continuity of antigen expression maintains immune system engagement and provides prolonged protective action, overcoming the limitation of single-dose antigen administration
Data Source
AI summary
The present invention provides a viral vector or bacterial vector, said vector comprising a nucleic acid sequence encoding a Hantavirus nucleoprotein or antigenic fragment thereof; wherein said vector is capable of inducing a protective immune response in a subject. The present invention also provides compositions and uses of the vector in methods of medical treatment.